Aetna considers enterocystoplasty (augmentation cystoplasty) medically necessary for the treatment of neurogenic bladder that is refractory to medication.
Aetna considers intravesical transurethral bladder stimulation experimental and investigational for the treatment of neurogenic bladder becasue its effectiveness has not been established.
A neurogenic bladder is the loss of normal bladder function caused by damage to part of the nervous system. It may result from a disease, an injury, or a birth defect affecting the brain, spinal cord, or nerves leading to the bladder, its outlet (the opening into the urethra from the bladder), or both.
Intravesical transurethral bladder stimulation is a diagnostic and rehabilitative technique for the neurogenic bladder. The ultimate goal of the treatment is to create conscious micturition control. The technique combines direct electrical stimulation of bladder receptors with visual biofeedback using patient observance of a water manometric representation of the detrusor response. The bladder is catheterized, and a slow-fill cystometrogram is performed. At the end of the cystometrogram, the bladder is emptied. This emptied volume is defined as the bladder capacity. The measured pressure at the end of the cystometrogram when bladder capacity is reached is defined as the bladder capacity pressure. Following the initial cystometrogram, the bladder is filled to half capacity. An initial 15-minute bladder observation period is followed by a 90-minute therapy session. Observations during the first treatment are used in setting initial parameters for future stimulation. Patients are usually treated with 20 out-patient sessions (a series) during which periodic adjustments are made depending on the response of the bladder to stimulation. Following the first series, a cystometrogram is performed, and the bladder is allowed to rest for approximately 3 to 6 months. At the next visit, a cystometrogram is repeated, and a subsequent course of stimulation sessions (5 to 15) is administrated for 1 to 2 weeks. Medications that may affect bladder dynamics are routinely discontinued a few days before urodynamic studies and during bladder stimulation therapy. The program is multi-staged, and not all patients require full therapy. Once the training process is completed, no additional therapy is usually necessary, and the results are permanent.
Boone et al (1992) conducted a prospective, randomized, sham controlled and blinded study on the efficacy of intravesical transurethral electrotherapy in treating urinary incontinence in the myelodysplastic child. A total of 31 children completed the protocol. Of the patients completing the study, 13 were randomly selected to serve as an internal sham control having the electrocatheter placed without activating the stimulator. These patients were subsequently treated with a 3-week course of electrotherapy. The remaining 18 patients completing the study were randomly selected to undergo 2 3-week courses of intravesical bladder stimulation. Urodynamic studies were performed before and after each treatment series. Detailed daily questionnaires were submitted to each participant covering subjective improvement in urinary continence and any development of bladder sensory awareness. Analysis of urodynamic data and questionnaires failed to reveal any statistically significant increase in bladder capacity, development of detrusor contractions, improvement in detrusor compliance, or the acquisition of bladder sensation allowing timely intermittent catheterization and preventing urinary incontinence.
Lyne and Bellinger (1993) reported on a study of patients with neurovesical dysfunction that were treated with transurethral electrical bladder stimulation. A total of 17 patients (2.5 years to 20 years) completed the series. All patients demonstrated detrusor contraction during therapy, and 88 % had sensation of contractions, usually developing later in therapy.
Decter et al (1994) published a follow-up report on the use of transurethral electrical stimulation in patients with neurogenic bladder. Since 1989, they performed 64 series in 25 patients with neurogenic bladders. A cystometrogram was performed before each series of stimulation to monitor progress, and impressions of the stimulation were obtained by a questionnaire. The initial evaluation cystometrogram before stimulation revealed that 18 patients (72 %) had bladder contractions. After electrical bladder stimulation, 24 patients (96 %) manifested contractions. Before stimulation, only 3 children sensed the contractions, while during stimulation 50 % of the patients perceived the contractions. A cystometogram performed before each series demonstrated a greater than 20 % increase in the age adjusted bladder capacity in 6 of the 18 patients (33 %) with serial studies. Improvements in the end filling pressure defined by clinically significant decrease were observed in 5 of these patients (28 %). The authors concluded that transurethral electrical bladder stimulation is a time-consuming, labor intensive technique, and the limited urodynamic benefits the patients achieved did not materially alter the daily voiding regimen. As a result, the authors were not enrolling any new patients into the program.
Cheng et al (1996) published the results of their continuing study (since 1984) on the use of intravesical transurethral bladder stimulation in children with neurogenic bladder. The authors examined data from multiple institutions and compared it to their own experience. A total of 335 patients had adequate and accurate pretreatment and post-treatment urodynamic studies, and were reviewed in the study. Bladder capacity and bladder capacity pressure were determined for each patient before and after therapy. Overall, 53 % of patients had increased bladder capacity of 20 % or greater after treatment, which represented a 63 % increase from pre-treatment values. The increase occurred in an average of 1.9 years. Further analysis of the patients revealed that in 90 % intravesical storage pressures were decreased or maintained within a safe range (less than 40 cm. water). Evaluation of patients who did not respond to bladder stimulation with a 20 % or greater increase in bladder capacity revealed that they had nearly normal bladder capacity before therapy. According to the authors, bladder stimulation is effective in increasing bladder capacity without significantly elevating storage pressure in a majority of patients. The technique is safe and effective in improving bladder compliance, and the program can be reproduced elsewhere. However many other institutions have conducted similar trials with mixed regard to the efficacy of the treatment modality, and that, to date, clinical experience with bladder stimulation has been too limited to permit identification of the cases that will succeed or fail with the therapy.
Hagerty et al (2007) evaluated their 22-year experience with intravesical electrotherapy in patients with neurogenic bladder. The charts of 405 patients who received intravesical electrotherapy were reviewed. Cystometrograms were performed at the start of each treatment series. Bladder capacity and pressure were determined for each patient before and after therapy. Patients were also questioned regarding the sensation of bladder filling. From 1985 to 2006, a total of 372 patients with an average age of 5.5 years (range of 0 to 43) had follow-up information available and were included for evaluation. Patients received a median of 29 treatment sessions (range of 2 to 197). Mean patient follow-up was 6.6 years (range of 0 to 19.7). Of the 372 patients, 286 (76.9 %) had a 20 % or greater increase in bladder capacity after treatment. In this subset of patients bladder storage pressure at capacity was normal (less than 40 cm water) in 74.4 % (213 of 286). Of the 17.2 % of patients (64 of 372) who had no change in bladder capacity 81.21 % (52 of 64) had normal bladder storage pressures after treatment. Bladder sensation was developed and sustained in 61.6 % of patients (229 of 372), including 33.6 % in the first series.
It is written in the 2011 textbook Wein: Campbell-Walsh Urology, intravesical electrotherapy, an old technique, which has been has been resurrected with some interesting and promising results is certainly controversial.
Enterocystoplasty, also called augmentation cystoplasty, is an enlargement of the bladder with a patch of small or large intestine or stomach. Clean intermittent catheterization is necessary after the procedure.
|CPT Codes / HCPCS Codes / ICD-10 Codes|
|Information in the [brackets] below has been added for clarification purposes.  Codes requiring a 7th character are represented by "+":|
|ICD-10 codes will become effective as of October 1, 2015:|
|CPT codes covered if selection criteria are met:|
|51960||Enterocystoplasty, including intestinal anastomosis|
|ICD-10 codes covered if selection criteria are met:|
|G83.4||Cauda equina syndrome|
|N31.0 - N31.9||Neuromuscular dysfunction of bladder|
Transurethral Electrical Bladder Stimulation: